Recent

% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • brh236 brh236 Sep 22, 2000 12:50 PM Flag

    bsx has new cardio products coming

    This refers to bsx as well.

    From todays
    Financial Post, comment by Patricia Nesbitt, senior
    vice-president in charge of Canadian
    equities at GWLIM (the
    investment management arm of Great-West Life Assurance
    Co.),
    point to the positive fundamentals underpinning the
    Canadian equity market and she hase selected ANP.to / ANPI
    Nasdaq from the biotchnology sector.


    -
    Angiotech Pharmaceuticals Inc. (ANP/TSE) $67 ($138-$10.30).
    This Vancouver-based
    biotech company develops new
    treatments for diseases involving abnormal
    cell
    development and chronic inflammation. The firm's lead product
    is a paclitaxel-coated
    cardiovascular stent, used
    to prevent scarring and reblockage of arteries
    following
    angioplasty procedures.

    One of Angiotech's partners,
    Cook Inc., has started clinical trials with these
    stents.
    Another partner, Boston Scientific Corp., is undertaking
    similar testing. Boston Scientific
    and Cook are two of
    the world's largest stent manufacturers and are
    "strong partners for
    Angiotech."

    The company is
    also in clinical studies of topical paclitaxel gel
    formulation for the
    treatment of psoriasis. Similar
    studies are underway in the treatment of
    rheumatoid
    arthritis and multiple sclerosis, say Nesbitt.

 
BSX
24.28-0.06(-0.25%)Jul 29 4:01 PMEDT